文献速递淋巴瘤白血病

Bcor缺失促进慢性淋巴细胞白血病向Richter转化并与小鼠中Notch1激活相关

Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice.
PubMed 文献 · Leukemia · 2025-03-20

研究在Eμ-TCL1小鼠的B细胞和CLL细胞中敲除Bcor,发现Bcor缺失改变B细胞区室并促进CLL转化为侵袭性淋巴瘤、缩短生存期;Bcor缺陷与脾脏CD19+CD5+细胞中Notch1激活相关,Notch1抑制可减少循环CD19+CD5+细胞和脾脏浸润RT细胞、减少PD-1表达T细胞并改善生存。

要点

  • Bcor敲除促进Eμ-TCL1小鼠CLL向侵袭性淋巴瘤转化并缩短生存。
  • Bcor缺陷与脾脏CD19+CD5+细胞中Notch1激活相关,加速淋巴增殖。
  • Notch1抑制减少循环CD19+CD5+和脾脏RT细胞、减少PD-1表达T细胞并改善生存。

核心结论

  • Bcor的抑癌活性与Notch1在RT发病机制中相互作用,具有肿瘤靶向潜力。
  • 该模型为探索这一不可治愈肿瘤的新替代方案提供了新平台。

研究设计与样本

  • 在Eμ-TCL1小鼠的B细胞和CLL细胞中敲除Bcor的工程化小鼠研究。
  • 采用RNA测序分析分子特征,并评估Notch1抑制对疾病的影响。

主要发现

  • Bcor缺失导致B细胞区室改变,并促进CLL转化为侵袭性淋巴瘤,Eμ-TCL1小鼠生存期缩短。
  • RNA测序显示类似人类RT的分子特征,并提示T细胞肿瘤微环境参与疾病发生。
  • Bcor缺陷与脾脏CD19+CD5+细胞中Notch1激活相关,加速Eμ-TCL1小鼠淋巴增殖。
  • Notch1抑制进行性减少患病小鼠循环CD19+CD5+细胞和浸润脾脏的RT细胞,同时减少表达PD-1的T细胞并改善生存。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Richter's transformation (RT) is an aggressive lymphoma occurring upon progression from chronic lymphocytic leukemia (CLL). Despite advances in deciphering the RT genetic architecture, the mechanisms driving this disease remain unknown. BCOR disruptive mutations were found in CLL and frequently associated with NOTCH1 aberrations, a common feature in CLL and RT. We engineered mice to knock-out Bcor in B and CLL cells of Eμ-TCL1 mice. Bcor loss resulted in alterations of the B cell compartment and favored CLL transformation into an aggressive lymphoma with reduced survival in Eμ-TCL1 mice. RNA-sequencing demonstrated a molecular signature reminiscent of human RT and implied the involvement of the T cell tumour microenvironment in the disease onset. Bcor deficiency was associated with Notch1 activation in splenic CD19 + CD5+ cells to accelerate Eμ-TCL1 mice lymphoproliferation. Notch1 inhibition progressively reduced circulating CD19+ CD5+ and RT cells infiltrating the spleen of diseased mice with concomitant reduction of PD-1 expressing T cells and improved survival. Our data demonstrated an interplay between the tumour suppressor activity of Bcor and Notch1 in RT pathogenesis with potential for tumour targeting. This model represented a new platform to uncover promising alternatives for this incurable tumour.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Rompietti C, Adamo FM, Sorcini D, et al. Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice. Leukemia. 2025. PMID: 40113912. doi:10.1038/s41375-025-02557-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。